What segments are in the U.S. Orthopedic Biomaterials market? The U.S. orthopedic biomaterials market includes bone graft substitutes, growth factors, cellular allografts, cell therapies, hyaluronic acid viscosupplementation, and cartilage repair. Bone graft substitutes fill bone voids or act as extenders to eliminate the need for autograft harvesting. Growth factors are naturally occurring proteins within the
Did you know there are over 8.9 million orthopedic procedures performed in the United States each year, with the orthopedic biomaterials market showing the greatest forecast growth? As this market continues to grow and innovative technologies are being designed, we have compiled a list of the top companies within different categories of the orthopedics market including: Orthopedic
The growing elderly demographic has been a considerable market driver within the orthopedic biomaterials market, the incidence of osteoarthritis and other forms of degenerative diseases have also been on the rise. In an effort to find a cure for such diseases researchers have been investigating the abilities of smart biomaterials. Smart biomaterials autonomously respond to
Researchers at Duke University have developed an adenosine-sequestering bone bandage able to naturally trap adenosine at the site of a break, accelerating recovery and improving bone repair. The research team observed an increase in adenosine levels in patients with bone injuries, however, the amount available to the break site may be limited depending on the
Register to receive a free Small Bone and Joint Devices Market Analysis, Size, and Trends Report synopsis and brochure. During a press release, there was a massive development in the small bone and joints market, where Wright Medical sold all issued and outstanding ordinary shares of the company to the Stryker Corporation. The agreement between
Register to receive a free Orthobiologics Market Analysis, Size, and Trends Report synopsis and brochure. When someone injures their knee and their cartilage becomes damaged, surgery is usually required to repair the tissue. Currently, microfracture is the most common type of operation to treat damaged cartilage. New Jersey-based Regentis Biomaterials, a global biomaterials company, is
Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Bone infections are notoriously tricky to treat, and antibiotics are frequently prescribed. Now, researchers at Georgia Tech have created a hydrogel material that can be used to treat bone infections and even prevent them from happening following surgery. The injectable hydrogel
Register to receive a free synopsis and brochure. Browse the Report Library. Arthrex is a global medical company focused in orthopedic product development and education, and was founded in 1981. Today it is a privately held organization headquartered in Southwest Florida. Arthrex has an additional global division in Germany and several subsidiaries and distribution centers in Europe,
Register to receive a free U.S. Market Report Suite for Orthopedic Biomaterials report synopsis and brochure Medtronic announced the launch of the Grafton™ Demineralized Bone Matrix (DBM) for spine and orthopedic procedures on February 28th, 2019. Grafton™ DBM is the first ever demineralized bone matrix product available in Japan, which is the world’s second largest
Register to receive a free Orthopedic Biomaterials Market Report Suite for US synopsis and brochure Allosource has recently enrolled the first patient in a study entitled “A Prospective, Multi-Center Study Evaluating ProChondrix® CR for the Repair of Focal Articular Cartilage Defects in the Knee”. Allosource is a prominent industry figure in advancing transplantable allogenic cells and tissue.
